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Pandemic (H1N1) 
2009 and HIV 
Co-infection
To the Editor: We report a case 
of pandemic (H1N1) 2009 infection 
in a man with serologic evidence of 
HIV-1 infection. The clinical course 
was complicated by lung and brain 
involvement (respiratory failure and 
lethargy), severe leukopenia, and 
thrombocytopenia, but complications 
resolved after treatment with oselta-
mivir (150 mg 2×/d).
In November 2009, a 47-year-old 
man who had received a diagnosis of 
hepatitis C infection 8 months earlier 
sought treatment at Ospedale Santa 
Maria Nuova, Reggio Emilia, Italy. He 
had a 3-day history of fever, dry cough, 
and drowsiness. Eight days before be-
ing admitted, the man had resided in 
the hospital’s inpatient detoxiﬁ  cation 
unit, in which at least 10 inﬂ  uenza-
like cases had been recorded. While in 
the detoxiﬁ  cation unit, he had received 
methadone, 50 mg 1×/d. Computed 
tomography images of the brain and 
radiographs of the chest were normal; 
ultrasound examination showed up-
per lobe consolidation of the left lung. 
Hematochemistry showed high cre-
atine phosphokinase levels, leukocyte 
count 1,380 cell/mm3 (reference range 
4,000–10,000 cells/mm3), thrombo-
cyte count 34,000 cells/mm3 (refer-
ence range 150,000–450,000 cells/
mm3), partial pressure of oxygen 56 
mm Hg, and partial pressure of carbon 
dioxide 53 mm Hg. Urinalysis results 
were negative for heroin, cocaine, and 
alcohol; cerebrospinal ﬂ  uid  (CSF) 
analysis results were within normal 
limits. Thrombocyte count returned to 
reference range after 2 days, and leu-
kocyte count improved but remained 
<3,500 cells/mm3 for 3 weeks. After 
admission to hospital, the man became 
lethargic and received noninvasive 
continuous positive airway pressure 
ventilation and treated with oseltami-
vir (150 mg 2×/d for 5 d), as well as 
with ceftriaxone, and levoﬂ  oxacin. 
Reverse transcription–PCR on a throat 
swab conﬁ  rmed  inﬂ  uenza  subtype 
H1N1 infection; blood cultures and 
urine were negative for pneumococ-
cus, and Legionella spp. antigens. In 
addition, PCR of CSF for enterovirus 
and herpesvirus had negative results. 
The patient needed respiratory support 
for 4 days, after which his mental sta-
tus and blood gases returned to refer-
ence levels. He was discharged from 
the hospital 2 weeks later. 
On day 3 after admission, a nurse 
was accidentally exposed to the pa-
tient’s urine through her eye. An 
ELISA was positive for HIV infec-
tion. Negative results for conﬁ  rmatory 
Western blot tests on days 5, 15, and 23 
showed the p24 and p41 bands; HIV 
RNA was >6 million copies/mL, CD4 
lymphocytes 51% (reference range 
29%–59%). Reverse transcription–
PCR for inﬂ  uenza subtype H1N1 per-
formed 2 months later on a stored CSF 
sample gave a negative result; PCR 
for HIV of the same sample indicated 
25,000 copies/mL. In mid-December, 
because of a further drop in CD4 lym-
phocytes to 17% (214 cells/mm3) and 
blood HIV RNA of 2.8 million copies/
mL, the patient started highly active 
antiretroviral therapy and is being fol-
lowed up as an outpatient.
Inﬂ   uenza (H1N1) and primary 
HIV infection share many signs and 
symptoms, such as fever, cough, sore 
throat, joint or limb pain, and diarrhea. 
The infections also share uncommon 
complications of the central nervous 
system (CNS); e.g., drowsiness, coma, 
and seizures. We cannot conﬁ  rm that 
CNS involvement in the patient re-
ported here was caused primarily by 
pandemic (H1N1) 2009, as suggested 
by inﬂ  uenza-like symptoms and the ap-
parent effect of oseltamivir. Nor can we 
attribute CNS involvement to primary 
infection with HIV-1 (1); CSF results 
within normal limits and PCR negative 
for inﬂ  uenza subtype H1N1 do not rule 
out a causal relationship with pandemic 
(H1N1) 2009. In fact, the few cases of 
pandemic (H1N1) 2009 encephalopa-
thy described show similar character-
istics among children and adults (2–4). 
Alternatively, some authors have at-
tributed HIV in CSF to brain inﬂ  am-
mation and damage (5,6). The severe 
leukocytopenia and thrombocytopenia 
in our patient have not been described, 
even in complicated inﬂ  uenza subtype 
H1N1 infections (7). Because lym-
phopenia and mild thrombocytopenia 
are the usual ﬁ  ndings, we believe that 
they probably resulted from HIV-1 or 
the effect of both viruses.
HIV seroconversion may initially 
occur during an acute febrile illness 
resembling inﬂ   uenza, and CNS in-
volvement can complicate both infec-
tions. During an epidemic, acute HIV 
infection should also be considered 
(8). Less frequently, as in the patient 
described above, the 2 infections can 
occur simultaneously. History of re-
cent risk behavior for blood exposure 
and severe leukocytopenia and throm-
bocytopenia should alert clinicians to 
other causes and prompt them to offer 
an HIV test to the patient. 
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Dictyostelium 
polycephalum 
Infection of Human 
Cornea
To the Editor: Although Dictyos-
telium spp. are used for studying signal 
transduction, cytoskeletal functions, 
endocytosis, and molecular pathogen-
esis of infectious and other diseases (1), 
human or animal infections caused by 
this organism have not been reported. 
We report a case of keratitis caused by 
Dictyostelium polycephalum in an im-
munocompetent person.
A 35-year-old man sought treat-
ment for redness, pain, and watering 
in the left eye of 11 days’ duration. He 
had no history of ocular injury or sur-
gery. At the time of his medical visit, 
he was using ophthalmic solutions of 
5% natamycin sulfate, 0.5% moxiﬂ  ox-
acin hydrochloride, and 0.3% gentam-
icin sulfate, each instilled every hour, 
and 1% atropine sulfate, 3×/d.
The vision in his right eye and 
results of a clinical examination were 
within normal limits. His left eye vi-
sual acuity was expressed as the abil-
ity to count ﬁ  ngers at 1 m. The eyelids 
were edematous and the conjunctivae 
were congested. The cornea showed 
a large central epithelial defect with 
underlying stromal inﬁ  ltrate and De-
scemet folds. The surrounding cornea 
had a mild cellular reaction. The ante-
rior chamber was deep, and the pupil 
was round, regular, and dilated. Iris 
and lens details could not be distin-
guished because of corneal haze. We 
obtained corneal scrapings, and the 
material was subjected to a detailed 
microbiologic analysis (2).
Microscopic examination showed 
double-walled spherical cysts in potas-
sium hydroxide with calcoﬂ  uor white 
stain, Gram stain (Figure, panels A, 
B), and Giemsa stain. On the basis of 
this ﬁ  nding, a presumptive diagnosis 
of Acanthamoeba keratitis was made. 
The patient was advised to use 0.02% 
polyhexamethylene biguanide and 
0.02% chlorhexidine eye drops every 
half hour and 1% atropine eye drops 
3×/d and was asked to return for a 
follow-up visit the next day. However, 
the patient did not return and could not 
be located. After 48 hours’ of incuba-
tion, a nonnutrient agar plate showed 
growth of double-walled, spherical 
cysts ≈6–7 μm in diameter that had 
different morphologic features than 
those of Acanthamoeba spp. cysts.
To identify the organism, we ex-
tracted DNA from the growth on non-
nutrient agar and subjected it to PCR 
speciﬁ  c  for  Acanthamoeba  spp. (3); 
results were negative. The extracted 
DNA was then subjected to 18S rDNA 
PCR for free-living amebas as de-
scribed by Tsvetkova et al. (4). A PCR 
product  ≈800 bp was obtained and 
subjected to bidirectional sequenc-
ing with ﬂ  uorescent-labeled dideoxy 
nucleotide terminators by using ABI 
3130 XI automated sequencer in ac-
cordance with the manufacturer’s in-
structions (PE Applied Biosystems, 
Foster City, CA, USA).
The Mega BLAST search pro-
gram (www.ncbi.nlm.nih.gov/blast/
megablast.shtml) of GenBank identi-
ﬁ  ed the sequence as D. polycephalum 
(99% similarity with AM168056). We 
deposited the sequence of our isolate in 
GenBank (accession no. GU562439). 
The organism showed cytotoxicity af-
ter in vitro inoculation of a rabbit cor-
neal epithelial cell line.
The patient sought treatment 4 
months after his initial visit. The left 
eye visual acuity was now expressed 
as the ability to see hand movements 
near the face. Slit-lamp examination 
showed lid edema and conjunctival 
congestion. The cornea showed a 
ring-shaped inﬁ   ltrate, central thin-
ning, surrounding corneal edema, and 
pigments on the endothelium (Figure, 
panel C); these ﬁ  ndings were identical 
to the clinical picture of Acanthamoe-
ba keratitis. Repeat corneal scrapings 
showed organisms of same morpho-
logic features seen on the ﬁ  rst visit by 
microscopy and culture. Organisms 
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